chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received Fluad in the left deltoid  and then received by mistake flulaval in the right arm.  Patient did not have any reaction and was cought by the pharmacist after the patient returned home.  The patient returned to the pharmacy and received Arexvy in the right arm an inch from the other.
On Sept 10, 2022, 4 days after the booster, my husband brought me to the hospital Emergency Room as I became very confused.  Kept repeating myself, very different behavior than usual.
SORE RIGHT ARM; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 15:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date the patient experienced sore right arm. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore right arm was unknown.   No follow-up attempts are needed. No further information is expected.
Note Text: Assessed res per NAR request. Res presenting with jerking tremors, irregular, in bil UE. Mouth tensed, jaw locked and teeth clenched. Eyes shut. Able to easily lift eyelids and check pupils-PEARRLA. VS 99.1-92-24-149/85-82% RA. RR 24, labored, shallow with 02 82%-88% RA while laying flat. Elevated HOB greater than 60 degrees, O2 91-94% RA. O2 85% upon lowering HOB. Continued poor food and fluid intake, increased body temperature. Upon AM cares res presented with blanchable erythema to R shoulder that measured about 10x10 cm. Res c/o pain with light touch, guarding R shoulder with mouth clenched. Area swollen. Cold compress applied. Upon later assessment with res tremoring, R shoulder erythema decreased, about 6x6 cm, irregular borders and slightly elevated. Erythema presenting light pink. Reapplied cold compress.
Patient is a 53-year-old male was admitted on 10/4 with concern for perirectal abscess Patient also has COVID-positive Chronic medical conditions CHF hypertension obesity Blood work reviewed showing leukocytosis and anemia  CT done showing perianal abscess
Information has been received from a 25 year old female consumer reporting on herself, with no pertinent medical history, no drug reactions/allergies, GARDASIL, a Pregnancy Registry product, who on an unspecified date was vaccinated with the third dose of GARDASIL (Lot #, dose and route not reported). There was no concomitant medication. The patient called to report that she got her third GARDASIL shot and later found out she was pregnant. Patient's last menstrual period was reported as approximately 02-AUG-2011. No lab diagnostic studies were performed. Follow up information was received from a physician's assistant concerning a patient with an obstetrical history of two pregnancies and two elective terminations and unknown birth defects or infant complications in previous pregnancies who was vaccinated at another office with the first two doses of GARDASIL, the first dose administered on 23-MAR-2011 (Lot #, dose and route not reported) and the second dose on 24-MAY-2011 (Lot #, dose and route not reported). The patient was vaccinated with the third dose of GARDASIL on 06-SEP-2011 (dose and route not reported) and lot # 670050/1229AA. The patient's last menstrual period was 02-AUG-2011 and estimated delivery date would be 08-MAY-2012. It was reported that all prenatal testing were unknown as of right now. No other medication was used during pregnancy. At the time of the report, the pregnancy outcome was unknown yet, the patient not due until 08-MAY-2012. A consent form was mailed to the patient. Follow up information has been received. The nurse reported that they had no idea about any baby information and also did not know the patient's OBGYN. As of now, the pregnancy outcome remains unknown. No further information is available.
about an hour after vaccination patient began experiencing coughing/wheezing, SOB, throat irritation.  woke up next morning with redness and rash to arms, stomach and back. patient took a total of 50 mg Benadryl which relieved symptoms. Symptoms lasted about 2 weeks. Patient has experienced symptoms in the past but not as bad. Patient is not allergic to eggs or any other immunizations that she is aware of.
Redness at injection site started 24-48 hours after injection. Currently still having pain at injection site and trouble lifting or grabbing thing with left arm.  Xray completed to see if it was broken.
Pain in area of injection site, numbness to left forearm, pain and numbness to left buttocks. Appears to be minor.
Chill, headache, dizziness, sore muscles, nauseated, tired.  for 2 days.  Milder headache &  dizziness for 2 more days so far
11/30/21 PM/ night - Patient developed fever 103, shivering, heartburn, tinnitis to both ears, fatigue. 12/2/21 - spoke with patient this morning.  All symptoms have resolved except temp 99
This 18-year-old female was vaccinated with Vivotif (Batch no.: unknown) on 18.Feb.2006. One day later, on 19.Feb.2006 the patient developed FEVER, ABDOMINAL CRAMPS, DIARRHEA, MYALGIA and HEADACHE. Outcome and treatment of reaction, complete recovery without treatment. The patient also received immunisation with Menactra on 16.Feb.2006. This case was forwarded by manufacturer reported. The case was reported to be non-serious.
Chills, sweats, pain at injection site, swelling at injection site, bruising at injection site, and a round ring at injection site
Information has been received from a physician referring to an unknown number of patients of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On unknown dates, on or after 01-APR-2016, the patients were vaccinated with improperly stored doses of PROQUAD (lot # L031603 with expiration date 18-FEB-2017, therapy type rHA; lot # M007965 with expiration date 15-AUG-2017, therapy type rHA; dose and route were not reported). It was reported that the vaccine was improperly stored at 35.47 Fahrenheit for 314 hours and 15 minutes. There was no previous excursion. Data logger was involved. No adverse effect was reported. Follow up information has been received from the physician on 24-OCT-2016. On 24-OCT-2016, a call was placed to the physician. The call was received by another physician. The physician reported that she would have to research the request made for patient identifiers, lot number and expiration date and dates of vaccination. Follow-up information was received on 09-NOV-2016 from an unspecified reporter, who provided the patient's demographics, and stated that the patient was vaccinated with an improperly stored dose of PROQUAD 0.5ml (unspecified dose) with lot number reported as K011188 (unspecified expiration date). No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information is not expected, as follow ups requested to complete the case were received.
still feeling a bit down from the shot on wednesday; Initial information received on 19-Oct-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves Adult patient of an unknown age and gender who experienced still feeling a bit down from the shot on wednesday after receiving Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a unknown dose of suspect Influenza vaccine produced by unknown manufacturer (strength, formulation, expiry date and lot number not reported) via unknown route in unknown administration site as Prophylactic vaccination (immunization). Information on the batch number was requested.  On 19-Oct-2023 the patient developed feeling a bit down from the shot on wednesday (malaise) (unknown latency).  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
LMP 7/15/2021 EDD 6/4/2022 1st Trimester Miscarriage
Warmth, erythema, swelling and tenderness below Adacel injection site. Started within 2 days after vaccine. Treated with Claritin and Keflex.
Chills evening of vaccine - 1/25/21 approximately 9PM Fatigue -1/26/21 approximately 3PM Chills, low grade fever, headache, fatigue 1/26/21 approximately 7:30PM Fever broke at 2AM 1/27/21 All Symptoms resolved by 5AM 1/27/21
Covid arm, entire arm red and inflamed, swollen lymphomas, neck glands hurt, severe headache, upset stomach
"Did not feel myself, felt achy and uncomfortable". Around injection site at upper arm, it is red, tender and warm to the touch.  The redness is about 5 inches in diameter at 1:00 on 10/31/2012.  Pt took 12.5 mg of Benadryl on 10/30/2012 for sleep aid.
Patient came to the pharmacy on 10/03/23 to report that after she received her annual influenza vaccine on 10/01/23, she felt very dizzy, had tingling and numbness in her bottom lip and on her tongue, as well as experienced headache.  She went to urgent care where she was seen for a suspected stroke or TIA. However, she was not diagnosed with anything and was discharged home. Patient reported that she took Tylenol and feels better today.
pt recv vax 4MAY97 & on 18MAY97 pt devel rash;
Following symptoms were experienced about 7 minutes aster receiving the vaccine: Feeling of warmth in abdomen followed by increased heart rate and palpitations. HR 148/min (normal resting heart rate 50-60/min). Blood measure 150/100 (baseline around 115/80). Also feeling of dry mouth. Observation prolonged - BP dropped to 130/90 after about 30 minutes, HR dropped to 80.  Episdoes of increased HR kept re-occurring for about 2 hours after the shot. No respitatory distress or cutaneous symptoms. After about 90 minutes after the vaccine, feeling tingling in lips and scratchy throat. Administered Benadryl 25mg per mouth, lip tingling and scratchy throat resolved within 30 minutes thereafter. All of the above symptoms resolved about 4 hours after the vaccine, HR at 60. Following symptoms developed within 12 hours of the vaccine: Chills, fever (100F), myalgia, artralgia, fatigue, nausea. Treated with ibuprofen and acetaminophen, resolved about 48 hours after the vaccine.  Note: No known history of Covid.
Low grade fever, headache, sore throat, tired, weak, insomnia, stomachache, nausea, vomiting, cough, sinus congestion, earache, hives.
3 days after receiving shot I broke out into severs hives all over my body, plus moderate fever and sore throat.  From Doctor's Visit Notes:  Developed fever,  Sore throat, hives 2-3 days after No wheezing, cp, diarrhea   No throat tightness
mild symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (mild symptoms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (mild symptoms). At the time of the report, VACCINATION COMPLICATION (mild symptoms) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.
Extreme soreness, ach, headache, burning hot to touch welp ironically lower than the actual injection size about the size of a half dollar, that was itchy and immediately gave way to a prickle mark. Monday it had intensified in size and red color. Very painful
Dystonia.  Presented to ED with marked muscle spasms and dystonia requiring multiple medications to terminate.
presented to clinic with complaints of R calf cramping for 15 days which had become acutely worse over the last week, especially bad when patient was walking. She has never experienced pain like this before. The R leg is also swollen from the calf down. She reports that sometimes the leg looks purple-ish and she endorses some tingling in the foot. Over the past couple weeks, she has also noted new dyspnea when walking. She denies fevers, chills, chest pain, palpitations, or cough. Of note, the patient had COVID-19 in November and since then has had some upper back pain which she currently has but it feels the same as usually does for her
vertigo; tinnitus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as single dose for covid-19 immunisation. Relevant medical history included: "tinnitus" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "vertigo"; TINNITUS (non-serious), outcome "unknown", described as "tinnitus".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
There is no adverse reaction, the vaccines was given to 17 yrs old patient. Talk to the patients's mom, Pt is doing good. there are no symptons of any reaction.
herpers zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 78 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 08-AUG-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster. On an unspecified date, the patient was treated by a physician for herpes zoster. The outcome of the event herpes zoster was not reported. The reporter considered the event herpes zoster to be related to zoster vaccine live (ZOSTAVAX).  Additional information has been requested.
Hives on lower extremities bilateral, upper extremities bilateral, severe itching - BENADRYL (50 mg PO given and epinephrine 0.5 mg SQ given at clinic then sent to ER.
Bells palsy on right side of face for four hours and went away.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 47-year-old female patient received BNT162b2 (BNT162B2), on 20Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 47 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (COVID-19 Vaccine: Dose 1, Manufacturer: Pfizer, Date: 27Mar2021 , LOT: ER2613, NDC/EXP: Unknown, Dose: Unknown, Route: Intramuscular injection to left arm, Had no effects from this dose.), administration date: 27Mar2021, when the patient was 47-year-old, for COVID-19 immunization; BNT162b2 (COVID-19 Vaccine: Dose 2, Manufacturer: Pfizer, Date: 17Apr2021 , LOT: EW0158, NDC/EXP: Unknown, Dose: Unknown, Route: Intramuscular injection to left arm), administration date: 17Apr2021, when the patient was 47-year-old, for COVID-19 immunization, reaction(s): "Tingling sensation that went down the right side of her arm", "Bells palsy on right side of face for four hours and went away". The following information was reported: BELL'S PALSY (medically significant), outcome "unknown", described as "Bells palsy on right side of face for four hours and went away.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16May2021) Positive, notes: Positive for COVID-19 virus on 16May2022. Clinical course: Please specify Antipyretic Use (around the date(s) of Vaccination): None. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pain in arm, having trouble holding items since vaccine has been given. Patient will probably seeking medical attention to help his arm feel better or for a  diagnosis
Partially paralyzed left hand, weakness in left hand (same day) Numbness in feet from instep forward
diagnosed with covid-19; diagnosed with covid-19; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  An 82-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "diagnosed with covid-19". The patient underwent laboratory test: SARS-CoV-2 test: Positive, notes: Diagnosed with Covid-19. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: patient has taken BNT162b2 vaccines and boosters.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sharp pain under left shoulder blade, palpitations, shortness of breath, would be woken by sharp pain thinking it was a possible heart attack, chest pain. When it first started it felt mild, I thought it was a pulled muscle, went to chiropractor and found it was not that and suggested a follow up with PCP. After a physical I was told it was probably a thyroid issue. Got a sonogram from thyroid doctor and was diagnosed with inflamed lymph nodes. No treatment issued. 10 days course and it went away.
Hurt right away, pain up shoulder and to neck. Woke up with severe migraine headache, vomiting, could not see. Ambulance called. Went to Hospital and transferred.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. Concurrent conditions, medical history and allergies were not reported. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of ROTATEQ lot # K010221, K011663, K016313 and lot # reported as K015816 (expiration dates, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information has been received from the medical assistant on 02-JUL-2015 concerning a patient of an unknown age and gender who on 12-MAY-2015 was vaccinated with a dose of ROTATEQ (lot # K015816) (dose and route not reported) that was 63 hours temperature excursion. This is one of several reports received from the same source. Additional information is not expected as all correspondence was received.
Severe total body shaking & shivering with normal body temperature - lasting about 2 hours. Total body aches & pains - lasting about 36 hours. Treated with rest & fluids. No ongoing issues.
After taking the shot caller experienced nauseousness and vomiting at around 8pm; After taking the shot caller experienced nauseousness and vomiting at around 8pm; feeling weak; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (feeling weak), VOMITING (After taking the shot caller experienced nauseousness and vomiting at around 8pm) and NAUSEA (After taking the shot caller experienced nauseousness and vomiting at around 8pm) in an 86-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2023, the patient received first dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 13-Oct-2023, after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced ASTHENIA (feeling weak). On 13-Oct-2023 at 8:00 PM, the patient experienced VOMITING (After taking the shot caller experienced nauseousness and vomiting at around 8pm) and NAUSEA (After taking the shot caller experienced nauseousness and vomiting at around 8pm). At the time of the report, ASTHENIA (feeling weak), VOMITING (After taking the shot caller experienced nauseousness and vomiting at around 8pm) and NAUSEA (After taking the shot caller experienced nauseousness and vomiting at around 8pm) was resolving.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. It was reported that after taking the shot caller experienced nauseousness and vomiting at around 8pm. She slept through the night and woke up feeling weak. No treatment information was provided.
Patient reported to pharmacy on 1/2/23 that she had been having pain about 1 month/at least 1 month prior to today.  She reports swelling of lymph nodes on back of neck/head.  On the right side, she says she has a pea size "knot" that is hard but not painful.  On the left side, lymph nodes swelling and very painful (golf ball size); she also reports nerve pain.  She says it is painful to open her mouth or touch the area.  She does report that she has a history of TMJ, but she does not believe she had done anything that would have triggered it during this time period.
Information has been received from a health professional concerning a 6 month old female who on 21-SEP-2006 was vaccinated with a dose of ROTATEQ (lot #654970/0777F). Additional information has been requested.
Tremors in arms and legs and fatigue, ongoing from approx. May, 1999. No treatment at this time. Seeing a neurologist at hospital.
Nine days after dose one of vaccine, I (patient) noted a red patch at and around the vaccine site, itchy and sore as on the first day of the inoculation.  On the twelfth day, this has almost returned to normal